If approved, how will MDMA-assisted therapy impact clinical psychiatry? The CEO of Lykos Therapeutics shares her thoughts.
Amy Emerson
Advertisement
Ms Emerson is the CEO Of Lykos Therapeutics.
Articles by Amy Emerson
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
FDA Issues CRL for CTx-1301 for Treatment of ADHD
2
Insights Into Mechanism-Based Biomarkers for Psychosis Prediction from Kim Do, PhD
3
New Name, New Path for Psychiatry: The Future of the DSM
4
Endangered Education: Psychiatric Professional Degrees Under Attack
5